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Objective: To investigate the feasibility of unsupervised community use of an array-based 1 
automated setup (AS) functional electrical stimulator (FES) for current foot-drop FES users. 2 
Design: A feasibility study.  3 
Setting: ParticipaŶts’ gait, total setup (TS) times and satisfaction were evaluated twice in the 4 
gait laboratory. Usage, AS times and problems encountered were recorded during a two 5 
week period of unsupervised use. 6 
Participants: Participants (N=7) with diagnosis of uni-lateral foot-drop of central 7 
neurological origin (>6mo), who were regular users of a foot-drop FES system (>3mo). 8 
Intervention: Array-based AS FES system for foot-drop (ShefStim). 9 
Main Outcome Measures: Logged usage; TS times for both FES systems and logged AS times 10 
for ShefStim; diary recording of problems experienced; Quebec User Evaluation of 11 
Satisfaction with assistive Technology (QUEST 2.0) questionnaire; walking speed; ankle 12 
angles at initial contact and foot clearance during swing. 13 
Results: All participants were able to use ShefStim. TS took longer with ShefStim than 14 
participaŶts’ oǁŶ FES systeŵs aŶd AS ǁas loŶger thaŶ iŶ a previous study of a similar system 15 
(1). Some problems were experienced but overall participants were as satisfied with 16 
ShefStim as their own FES systems. The increase in walking speed (N=7), relative to no 17 
stimulation, was comparable between both systems and appropriate ankle angles at initial 18 
contact (N=7) and foot clearance during swing (N=5) were greater with ShefStim. 19 
Conclusions: This study demonstrates, for the first time, that an array-based AS FES system 20 
(ShefStim) for foot-drop can be successfully used unsupervised. Despite setup taking longer 21 
and some problems users are satisfied with it and it would appear as effective, if not better, 22 
at addressing the foot-drop impairment. Further product development of this unique 23 
system, followed by a larger-scale and longer-term study is required before firm conclusions 24 
about its efficacy can be reached. 25 
Word count: 290 26 
Key words: electric stimulation therapy; peroneal nerve; hemiplegia; gait disorders, 27 
neurologic; rehabilitation 28 
Abbreviations: 29 
Functional electrical stimulation=FES ; Automated setup=AS; Odstock drop foot 30 
stimulator=ODFS; Inter-quartile range=IQR; Standard deviation=SD; Total setup=TS; Quebec 31 
User Evaluation of Satisfaction with assistive Technology=QUEST; Dorsiflexion=DF; 32 
Plantarflexion=PF 33 
 34 
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INTRODUCTION 35 
 36 
The efficacy, and safety, of functional electrical stimulation (FES) as a treatment for foot-37 
drop of central neurological origin is well established (2), however, usability issues have 38 
been noted (3, 4). In fact a survey of new and established users of the Odstock drop foot 39 
stimulator found that 44% of users reported difficulties in locating the correct electrode 40 
position (4), and this finding is of particular relevance to this study. Traditional single-41 
channel surface foot-drop FES systems deliver current via a pair of electrodes, accurate 42 
placement of which is crucial to the correct functioning of the system. The optimal site for 43 
stimulation may vary from day-to-day and even throughout a day which further complicates 44 
the setup process (4). Interestingly, despite wide recognition of this issue (5), only one study 45 
specifically reported on the impact of user-defined electrode placement on functional 46 
outcomes (1), finding a poorer foot response when participants  located electrodes 47 
themselves, compared with clinician setup.  48 
In response to this issue, new designs of FES systems have been produced. These include 49 
electrodes integrated into cuffs (6, 7) and implantable systems (5, 8). Most recently, Heller 50 
et al. (1) reported on an array-based FES stimulator for foot-drop.  The system uses the 51 
principle of a ͚ǀirtual electrode’. Stimulation is delivered via a 4x4 cluster of small 52 
electrodes, chosen from within an 8x8 array. The choice of which virtual electrode to use 53 
and at what level to stimulate is determined automatically during setup by an algorithm, 54 
which uses as its input the foot response to stimulation. This approach fully automates the 55 
setup process (both location and amplitude of stimulation) thus, potentially, reducing setup 56 
difficulty. Heller’s study found that automated setup (AS) was comparably effective and 57 
quicker than user setup conventional FES. The system, originally studied by Heller, has been 58 
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further developed and CE marked as ShefStim.  This paper is the first feasibility (9) study of 59 
ShefStim which combined a period of unsupervised use in conjunction with gait evaluation 60 
at the start and end of the study period. The primary aim was to investigate whether 61 
ShefStim could be used, unsupervised, by foot-drop FES users within the community 62 
environment. In addition a number of other sub-aims were addressed. These were to 63 
investigate: 64 
1. The community-usage patterns and user-satisfaction with ShefStim. 65 
2. The total setup (TS) time compared with their own FES system, as well as AS times 66 
for ShefStim. 67 
3. The effects of ShefStim on walking speed, ankle angles (at initial contact) and foot 68 
clearance during swing, compared with participaŶts’ own FES system. 69 
Word count: 404 70 
METHODS 71 
ShefStim system 72 
A detailed description of the operating principles of the stimulator, and changes in order to 73 
achieve CE marking, are given in the Heller et al. paper (1). The same fixed parameters 74 
(monophasic waveform, charge-balanced, 40Hz, 160µs) were used but the system used in 75 
Heller’s study restrained the leg in a support during the AS process. This was deemed 76 
impractical for a take-home device so instead users were requested to extend their leg and 77 
rest their heel on the floor during home AS.  78 
Figure 1:  79 
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The ShefStim consists of (Fig. 1): a leg-worn stimulator (Fig. 1. a.) housed in a modified knee 80 
sleeve
i
 (Fig. 1. b.); a flexible printed circuit board array of 64 electrodes (cathode electrodes)  81 
(Fig. 1. c.), covered with a thin layer of high resistivity hydrogel (10-12) . Sweat ingress 82 
changes the conductive properties of the hydrogel sheet so a replacement array fitted with 83 
a new sheet of hydrogel is used each day (12); a conventional footswitch
ii
;  a conventional 84 
anode
iii
 (Fig. 1.d.) and a foot sensor and remote control device housed in a bespoke foot-85 
pod
iv
 (Fig. 1. e.). The foot sensor and remote control device detects foot orientation, 86 
provides voice commands during AS and acts as a handheld remote unit post AS, allowing 87 
the user to pause, and change intensity as required.  88 
Word count: 209 89 
Donning the system 90 
To don ShefStim the following steps are required: 91 
1. The footswitch (Fig. 1. f.) is placed under the heel, with the connecting cable 92 
extending from the shoe. 93 
2. The knee sleeve is donned aligning the stimulator pocket with the long axis of the 94 
tibia  95 
3. The stiŵulator is placed iŶ the kŶee sleeǀe’s stiŵulator pocket  96 
4. The foot-pod, containing the foot sensor and remote control device is positioned 97 
over the shoe locating it approximately centrally over the dorsum of the foot and 98 
attached with Velcro®  99 
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5. Electrode array placement: the centre of the third row of electrodes down from the 100 
top of the array is aligned with the head of the fibula and the inner edge parallel to 101 
the tibia.  102 
6. The electrical connector for the array (Fig. 1. g.) is inserted into the array socket on 103 
the side of the stimulator and the array is secured with a Velcro® strap. 104 
7. The self-adhesive anode is positioned over the tibialis anterior. 105 
8. The footswitch connector (Fig. 1. h.) is inserted in the stimulator. 106 
AS is then started.  107 
Word count: 177 108 
AS 109 
For a more detailed description of the AS algorithm refer to Heller’s study (1). The only 110 
difference between the algorithm used in Heller’s study (1) and the ShefStim algorithm, 111 
relates to the cost function used in stage 3 of the setup process. The cost function enables 112 
many factors that are not directly comparable (e.g. the angle of dorsiflexion (DF) and the 113 
stimulation current) to be combined into one optimisation routine. In this case, for example, 114 
the angle of DF and the stimulation current are related and the benefits of increasing DF 115 
have to be balanced against the potential disadvantages of increasing current excessively. 116 
The cost function attributes each a cost score, the lower the cost the better, and the 117 
optimisation routine is used to find a minimum cost solution. Compared with the cost 118 
fuŶctioŶ descriďed iŶ Heller’s study, the one used in ShefStim reduced the degree of 119 
eversion associated with zero cost from 10 to 5 degrees. This change was implemented 120 
following observation of excessive (>10 degrees) eversion in 19% of Heller’s participants. 121 
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Word Count: 171 122 
Participants 123 
Ethical Approval was granted from the University of Salford (REP10/113) and the integrated 124 
research application system (10/H1003/107) for ten participants. Existing foot-drop FES 125 
users within the North-West region were given information by clinicians. Interested 126 
participants contacted the chief investigator. Inclusion/exclusion criteria are shown in Table 127 
1. 128 
Table 1:  129 
Word count: 46 130 
Protocol 131 
At visit 1 participants attended the University of Salford gait laboratory and were provided 132 
with standard shoes
v
  for all conditions to avoid the potential impact of different footwear  133 
on foot clearance  (13). Participants walked approximately five metres along the gait 134 
laboratory up to five times at a self-selected speed initially with no stimulation and then 135 
with participaŶt’s own FES system (self-setup). Following visit 1 the knee sleeve, stimulator 136 
and electrode arrays were prepared for that individual. Participants returned for visit 2 137 
where fitting was completed, rising/falling ramps and extension configured, adjustments 138 
made to AS settings if required (to ensure appropriate virtual electrode selection) and 139 
ShefStim use taught. Following two weeks of unsupervised use of ShefStim at home (with a 140 
home-visit after approximately one week to replenish arrays and answer any queries) 141 
participants returned to the gait laboratory (visit 3) which duplicated visit 1 but using 142 
ShefStim rather than their own FES system. 143 
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Word count: 151 144 
Measures 145 
Estimate of usage (between visits 2 and 3) 146 
Usage data has been collected in previous foot-drop FES studies (14-18). ShefStim logs the 147 
number of heel lifts per day which can be used as an estimate of usage.   148 
Word count: 29 149 
TS (visits 1 and 3) and AS time (between visits 2 and 3). 150 
With one notable exception (1), setup time has been largely neglected in previous foot-drop 151 
FES research . TS times, defined as time from first starting to don equipment to being 152 
satisfied with the outcome and walking away (including AS time for ShefStim), were 153 
recorded for participaŶts’ oǁŶ FES ;ǀisit ϭͿ aŶd ShefStim (visit 3). Average AS time (time for 154 
AS to complete) was logged by ShefStim.  155 
Word count: 65 156 
Diary recording problems during community use (between visits 2 and 3). 157 
Problems encountered were recorded in a paper diary by each participant. User-reported 158 
problems have been collected previously (15) but never during the period of use. Recorded 159 
problems were collated and grouped into two categories (19): External and Setup. External 160 
were classed as being independent of the stimulator design and so referred to the housing 161 
of ShefStim (knee sleeve), issues with the standard wired footswitch or issues with charging. 162 
Setup was defined as any problem related to setup or satisfaction with the foot response. 163 
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Word count: 81 164 
User-satisfaction (visits 1 and 3) 165 
User-satisfaction has previously been captured using purposive questionnaires (4, 15, 18). 166 
Given the risk of bias and lack of validation we sought an alternative. The Quebec User 167 
Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) device scale (20) is a 168 
validated user-satisfaction measure . Participants rated their satisfaction against eight single 169 
item criteria (dimensions, weight, ease of adjustment, safety and security, durability, ease of 170 
use, comfort, effectiveness) using a five-point Likert scale (1=not satisfied at all to 5= very 171 
satisfied: maximum score=40) for their own FES system and ShefStim.  In addition, 172 
participants ranked their top three priorities from the eight criteria. 173 
Word count: 97 174 
Speed and ankle angles at initial contact (visits 1 and 3) 175 
Increased walking speed indicates an improvement in overall walking performance (21) and 176 
is frequently used in FES research (22, 23). Measuring walking speed over five metres from a 177 
static starting position is a validated measure with neurological populations (24) and was 178 
calculated by averaging the velocity of a recorded waist marker (L3 vertebra) over the 179 
measurement space (13).  180 
Foot-drop leads to abnormal joint alignment during stance (25) with a tendency for 181 
plantarflexion (PF) and inversion (21) which can reduce ankle stability. Sagittal and frontal 182 
plane ankle angles were captured at initial contact to measure this. The calibrated 183 
anatomical system technique (CAST)(26, 27) was used for shank marker placement. Foot 184 
marker placement was based on the shod-foot model by Pratt et al. (28). 185 
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Data for both speed and ankle angles was captured at 100Hz using a 16-camera 3D motion 186 
analysis system
vi
; a fourth-order low-pass Butterworth filter was used with a 6Hz cut-off 187 
frequency. Ankle angles at initial contact were analysed using Visual 3D
vii
 188 
Word count: 152 189 
Foot clearance during swing (visits 1 and 3) 190 
Foot-drop is associated with an increased risk of tripping and falling due to a lack of foot 191 
clearance during swing phase (29). Foot clearance was obtained for seven different points 192 
on the shoe sole as described in Thies et al (13). Only three of the seven markers from Thies’ 193 
study (13) (distal toe, medial and lateral forefoot) were investigated since these were 194 
deemed most relevant. Healthy gait consistently has a minimum clearance value during 195 
swing (13, 30). Hemiplegic gait, however, has an altered clearance trajectory and does not 196 
always produce a minimum value during swing, so an alternative and consistently definable 197 
point along the trajectory was chosen. Specifically, in this study it was calculated at the 198 
moment in time when the reference point on the shoe sole passed the contra-lateral medial 199 
malleolus.  Data was processed using Matlab®
viii
 code (13). 200 
Word count: 133  201 
Total methods word count:  1311 (not including sub-headings)   202 
Data Analysis 203 
As a feasibility study (9, 31), statistical analysis was limited to graphical representation of 204 
data and descriptive methods. Ratio data (AS log data, speed and ankle angles at initial 205 
contact) was analysed using mean and standard deviation (SD). Median was used for 206 
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skewed data (usage, TS times and toe clearance (32) , with inter-quartile range(IQR)) and 207 
ordinal data (QUEST (33)).  208 
Word count: 56 209 
RESULTS 210 
Table 2:  211 
Table 2 provides participant characteristics. Prior to data collection three participants were 212 
withdrawn (1, 6, 10). The withdrawal of participants 1 and 10 was due to unrelated medical 213 
issues. Subject 6 was withdrawn as it became clear, post recruitment, that he was not a 214 
regular user of FES for foot-drop. He had discontinued use following ankle instability 215 
problems and a number of falls. The average age of the remaining  participants was 58 yrs. 216 
(SD 12.9) which is comparable to other foot-drop FES studies (1, 21, 34). Of the five men and 217 
two women, four had non-progressive and three had progressive neurological disorders, 218 
which is representative of the FES user population (16, 35). The FES systems used by 219 
participants varied but all use a single cathode and single anode, and so were classed as 220 
͚coŶǀeŶtioŶal’. 221 
Word count: 126 222 
Estimate of usage 223 
All participants used ShefStim (Fig. 2) with an average of 1314 heel lifts (steps) per day. 224 
There was variability in the number of heel lifts from day-to-day for each participant (for 225 
example participant 8) and between participants (participants 5 and 7 versus participant 3). 226 
The number of days participants used ShefStim within the two week period also varied, with 227 
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participants 7 (6/15) and 9 (4/15) using it far less than participants 5 (14/15) or 2 (13/15) 228 
(Fig. 2) 229 
Word count: 78 230 
 231 
Figure 2:  232 
 233 
TS and AS time 234 
TS time for ShefStim took an average of exactly 14 min [range: 12 min 24 s -37 min 30 s] 235 
compared to 3 min 20 s [range: 40 s -8 min] for their own FES. The average AS time was 9 236 
min [range: 7 min 34 s – 10 min 20 s]. 237 
Word count: 51 238 
 239 
Diary recording problems during community use 240 
Of the recorded problems 64% [48 problems] were related to setup with poor voice 241 
command clarity from the foot sensor and remote control device (e.g. participant 2, day 3 242 
͞reŵote ǀoice garďled͟Ϳ, frequent pausing during and/or unacceptable AS specifically cited 243 
(e.g. participant 5, day 9 ͞pausiŶg, ǁhy?͟ aŶd participaŶt Ϯ, day 2 ͞2x setups as chaplin 244 
ǁalk͟Ϳ. 36% [27 problems] were related to external issues, for example participant 8, day 6 245 
͞despite chargiŶg oǀerŶight coŶtroller ďattery ǁas flat͟. The overall number of reported 246 
problems diminished towards the end of the testing period (Fig. 3). 247 
Word count: 94 248 
 249 
Figure 3:  250 
 251 
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User-satisfaction 252 
Overall, on average, participants were as satisfied with ShefStim as with their own FES 253 
system (Fig. 4). They ǁere ŵore satisfied ǁith their oǁŶ FES iŶ terŵs of: ͚Ease of use’, ǁhich 254 
ǁas the criteria ŵost freƋueŶtly prioritised oŶ QUEST, aŶd ͚safety aŶd security’. ShefStiŵ 255 
outscored participaŶts’ own FES with regards to ͚effectiǀeŶess’, the secoŶd ŵost freƋueŶtly 256 
cited priority, aŶd ͚ease of adjustŵeŶt’. OŶ the reŵaiŶiŶg four criteria the systeŵs scored 257 
equally. 258 
Word count: 72 259 
Figure 4:  260 
 261 
Speed 262 
Both FES systems produced the same increase in walking speed [0.06 m/s] compared to no 263 
stimulation (Table 3).  264 
Word count: 18 265 
 266 
Table 3:  267 
 268 
Ankle angles at initial contact 269 
With no stimulation PF with inversion was seen (Table 3). Both ShefStim and conventional 270 
systems corrected this; however, ShefStim achieved this to a greater extent (Table 3). 271 
Word count: 27 272 
 273 
Foot clearance during swing 274 
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This outcome could not be determined for participants 5 and 7 who both exhibited short 275 
step lengths and a significant degree of external rotation of the leg during swing, therefore 276 
none of the reference points passed the contra-lateral malleolus during swing as was 277 
required by the algorithm. The distal toe marker showed the smallest overall clearance 278 
values and with ShefStim the clearance was greatest (Table 3). Table 3 shows that without 279 
FES, the median value of the medial marker was higher than the lateral; with participant’s 280 
own FES they were approximately equal and with ShefStim the lateral was higher than the 281 
medial. This foot pose at mid-swing was consistent with the ankle angles at initial contact 282 
(see above). 283 
Word count: 118 284 
Total results word count: 584 (excluding sub-headings) 285 
 286 
 287 
DISCUSSION 288 
This study sought to investigate the feasibility of unsupervised use of ShefStim by FES users 289 
within the community environment. Usage results show ShefStim is a usable device because 290 
without exception, albeit with variation, all participants used ShefStim. 291 
Previous studies have reported a number of different measures of usage (6, 14, 15, 17, 18). 292 
Only our results for steps (heel lifts) per day could be compared to previous, larger, studies 293 
(6, 15, 18), with our participants generally walking less. For example Stein et al’s (6) 294 
participants took 1842 (+/- 198) steps per day when first starting to use the Walkaide 295 
system and van Swigchem et al’s (18) took 5733 (SD 2516).  Worthy of note was that van 296 
Swigchem et al’s (18) participants were encouraged to wear the NESS L300 for the entire 297 
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day whereas participants in ours and Stein et al’s were not guided in this way. Further, our 298 
participants reported a number of problems associated with the pre-commercial nature of 299 
the ShefStim system, which may have impacted on use on certain days (see Fig. 3). Further 300 
studies should continue to report detailed FES usage to allow further exploration of the 301 
population and allow comparison between systems and/or baseline.  302 
Results did not fully meet the prediction made by Heller et al (1) that ShefStim would result 303 
in shorter TS times. There are a number of possible reasons for this. Firstly, Heller used self-304 
report to assess setup tiŵe ǁith participaŶts’ oǁŶ FES systeŵs, fiŶdiŶg aŶ aǀerage of ϭϭ 305 
minutes. In our study participants were timed during setup in the lab and took an average of 306 
3 minutes to setup their own FES systems. In the Heller study participants placed their 307 
affected leg in a rigid brace, thereby removing the possibility of significant leg movement. In 308 
our study, the participaŶt’s leg ǁas Ŷot coŶstraiŶed duriŶg setup aŶd leg movement 309 
detected during the AS process led to pauses which lengthened the process, a problem 310 
recorded by participants.  Further, our ShefStim users relied on audio feedback from the 311 
foot sensor and remote control device, which participants reported was sometimes difficult 312 
to hear. Participants also sometimes reached the end of setup and decided that the 313 
autoŵatically choseŶ site ǁas Ŷot acceptaďle, theŶ raŶ the eŶtire AS agaiŶ. Although a ͚skip-314 
site’ fuŶctioŶ ǁas aǀailaďle (1) to address this issue (alternative sites identified as suitable to 315 
be selected manually) participants did not use it, hence further refinement of user training 316 
material and/or the user interface is warranted.  317 
The finding that, overall, participants were as satisfied with ShefStim as with their own FES 318 
systems, is encouraging because unlike conventional foot-drop FES systems ShefStim has 319 
not been subject to significant product design. The fact that problems diminished and ͚ease 320 
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of use’ was rated lower than participants own FES systems, however, suggests that two 321 
weeks was insufficient for participants to fully familiarise themselves with ShefStim. 322 
Alternatively it might be due to the cited problems with ShefStim itself. Our results cannot 323 
be compared to other studies as QUEST has not been used before in this field of research. 324 
Future studies should allow longer unsupervised periods of use and should use a validated 325 
measure such as QUEST.  326 
Speed increase, for both ShefStim and conventional FES systems, compared to no FES was in 327 
keeping with previous studies (21) and classed as clinically meaningful (36). IŶ Heller’s study, 328 
in which subjects did not have time to accommodate to the automated setup,  speed 329 
increase (relative to no FES) when using the automated setup system was smaller than with 330 
their own system (0.04 m/s vs 0.11m/s). In both studies foot response with AS was 331 
iŵproǀed coŵpared ǁith participaŶts’ setup of their oǁŶ stiŵulators. Although there is a 332 
risk of over-interpretation of the results, our findings may suggest that once users become 333 
accustomed to a new FES system, their walking speed is relatively insensitive to small 334 
differences in foot response. These findings are supported by the foot clearance results and 335 
indicate that the underlying operating principle of an array-based FES system with AS may 336 
be more effective at addressing foot-drop than conventional FES systems by reducing 337 
human error/influence over electrode placement. However, larger scale study is required to 338 
fully substantiate these initial findings.  339 
Word count: 676 340 
Study limitations  341 
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This was a feasibility study with a small sample size, self-referred participants and was not 342 
randomised (9, 31). As such, whilst encouraging, results should be viewed with caution. The 343 
outcome measures selected would appear appropriate but many have been largely unused 344 
in previous research in this field making comparison to previous studies challenging. 345 
Further development of the electrode-skin interface is required (12) to negate the need for 346 
daily array replacement and improve future commercial viability. Further iterations of 347 
ShefStim need to also consider addressing the cited setup and external problems, such as 348 
voice command clarity, the impact of pausing on AS time, user training and charging, to 349 
facilitate further study and widespread implementation.  350 
Word count: 110 351 
 352 
CONCLUSION 353 
This is the first study of ShefStim and one of very few investigating foot-drop FES both 354 
within the lab and during unsupervised use (37, 38). Ultimately this study demonstrates, for 355 
the first time, an array-based AS FES system (ShefStim) for foot-drop can be successfully 356 
used unsupervised. Despite longer and more problematic setup in the population studied, 357 
users were satisfied with it and it would appear to have comparable, if not better, effects on 358 
gait than conventional foot-drop FES systems. 359 
Further product development and a larger-scale, longer-term study is required before firm 360 
conclusions about the efficacy and effectiveness of ShefStim, compared to conventional FES, 361 
can be reached. 362 
Word count: 104 363 
Total word count: 3245 364 
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iv
 Adapted from an I-pod holder, Signalex, Birmingham, UK. 
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 Hotter Comfort Concept shoes, Skelmersdale, UK. (for men) and Clarks Un Betty from 
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 C-Motion, Maryland, USA. 
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Figure legends 
 
 
Figure 1: ShefStim system (medial view of leg during AS) 
Figure 2: Logged heel lifts (N=7): Blank cells=0 heel lifts; the length of bar represents the number of 
heel lifts. The median number overall of steps per day was 1314. 
 
Figure 3: Recorded problems over two week unsupervised community use (N=7). 
 
Figure 4: Median QUEST results. Black= own FES system; Grey= ShefStim (n=7). Both systems 
scored a total of 32 out of 40. 
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Objective: To investigate the feasibility of unsupervised community use of an array-based 1 
automated setup (AS) functional electrical stimulator (FES) for current foot-drop FES users. 2 
Design: A feasibility study.  3 
Setting: ParticipaŶts’ gait, total setup (TS) times and satisfaction were evaluated twice in the 4 
gait laboratory. Usage, AS times and problems encountered were recorded during a two 5 
week period of unsupervised use. 6 
Participants: Participants (N=7) with diagnosis of uni-lateral foot-drop of central 7 
neurological origin (>6mo), who were regular users of a foot-drop FES system (>3mo). 8 
Intervention: Array-based AS FES system for foot-drop (ShefStim). 9 
Main Outcome Measures: Logged usage; TS times for both FES systems and logged AS times 10 
for ShefStim; diary recording of problems experienced; Quebec User Evaluation of 11 
Satisfaction with assistive Technology (QUEST 2.0) questionnaire; walking speed; ankle 12 
angles at initial contact and foot clearance during swing. 13 
Results: All participants were able to use ShefStim. TS took longer with ShefStim than 14 
participaŶts’ oǁŶ FES systeŵs aŶd AS ǁas loŶger thaŶ iŶ a previous study of a similar system 15 
(1). Some problems were experienced but overall participants were as satisfied with 16 
ShefStim as their own FES systems. The increase in walking speed (N=7), relative to no 17 
stimulation, was comparable between both systems and appropriate ankle angles at initial 18 
contact (N=7) and foot clearance during swing (N=5) were greater with ShefStim. 19 
Conclusions: This study demonstrates, for the first time, that an array-based AS FES system 20 
(ShefStim) for foot-drop can be successfully used unsupervised. Despite setup taking longer 21 
and some problems users are satisfied with it and it would appear as effective, if not better, 22 
at addressing the foot-drop impairment. Further product development of this unique 23 
system, followed by a larger-scale and longer-term study is required before firm conclusions 24 
about its efficacy can be reached. 25 
Word count: 290 26 
Key words: electric stimulation therapy; peroneal nerve; hemiplegia; gait disorders, 27 
neurologic; rehabilitation 28 
Abbreviations: 29 
Functional electrical stimulation=FES ; Automated setup=AS; Odstock drop foot 30 
stimulator=ODFS; Inter-quartile range=IQR; Standard deviation=SD; Total setup=TS; Quebec 31 
User Evaluation of Satisfaction with assistive Technology=QUEST; Dorsiflexion=DF; 32 
Plantarflexion=PF 33 
 34 
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INTRODUCTION 35 
 36 
The efficacy, and safety, of functional electrical stimulation (FES) as a treatment for foot-37 
drop of central neurological origin is well established (2), however, usability issues have 38 
been noted (3, 4). In fact a survey of new and established users of the Odstock drop foot 39 
stimulator found that 44% of users reported difficulties in locating the correct electrode 40 
position (4), and this finding is of particular relevance to this study. Traditional single-41 
channel surface foot-drop FES systems deliver current via a pair of electrodes, accurate 42 
placement of which is crucial to the correct functioning of the system. The optimal site for 43 
stimulation may vary from day-to-day and even throughout a day which further complicates 44 
the setup process (4). Interestingly, despite wide recognition of this issue (5), only one study 45 
specifically reported on the impact of user-defined electrode placement on functional 46 
outcomes (1), finding a poorer foot response when participants  located electrodes 47 
themselves, compared with clinician setup.  48 
In response to this issue, new designs of FES systems have been produced. These include 49 
electrodes integrated into cuffs (6, 7) and implantable systems (5, 8). Most recently, Heller 50 
et al. (1) reported on an array-based FES stimulator for foot-drop.  The system uses the 51 
principle of a ͚ǀirtual electrode’. Stimulation is delivered via a 4x4 cluster of small 52 
electrodes, chosen from within an 8x8 array. The choice of which virtual electrode to use 53 
and at what level to stimulate is determined automatically during setup by an algorithm, 54 
which uses as its input the foot response to stimulation. This approach fully automates the 55 
setup process (both location and amplitude of stimulation) thus, potentially, reducing setup 56 
difficulty. Heller’s study found that automated setup (AS) was comparably effective and 57 
quicker than user setup conventional FES. The system, originally studied by Heller, has been 58 
  
3 
 
further developed and CE marked as ShefStim.  This paper is the first feasibility (9) study of 59 
ShefStim which combined a period of unsupervised use in conjunction with gait evaluation 60 
at the start and end of the study period. The primary aim was to investigate whether 61 
ShefStim could be used, unsupervised, by foot-drop FES users within the community 62 
environment. In addition a number of other sub-aims were addressed. These were to 63 
investigate: 64 
1. The community-usage patterns and user-satisfaction with ShefStim. 65 
2. The total setup (TS) time compared with their own FES system, as well as AS times 66 
for ShefStim. 67 
3. The effects of ShefStim on walking speed, ankle angles (at initial contact) and foot 68 
clearance during swing, compared with participaŶts’ own FES system. 69 
Word count: 404 70 
METHODS 71 
ShefStim system 72 
A detailed description of the operating principles of the stimulator, and changes in order to 73 
achieve CE marking, are given in the Heller et al. paper (1). The same fixed parameters 74 
(monophasic waveform, charge-balanced, 40Hz, 160µs) were used but the system used in 75 
Heller’s study restrained the leg in a support during the AS process. This was deemed 76 
impractical for a take-home device so instead users were requested to extend their leg and 77 
rest their heel on the floor during home AS.  78 
Figure 1:  79 
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The ShefStim consists of (Fig. 1): a leg-worn stimulator (Fig. 1. a.) housed in a modified knee 80 
sleeve
i
 (Fig. 1. b.); a flexible printed circuit board array of 64 electrodes (cathode electrodes)  81 
(Fig. 1. c.), covered with a thin layer of high resistivity hydrogel (10-12) . Sweat ingress 82 
changes the conductive properties of the hydrogel sheet so a replacement array fitted with 83 
a new sheet of hydrogel is used each day (12); a conventional footswitch
ii
;  a conventional 84 
anode
iii
 (Fig. 1.d.) and a foot sensor and remote control device housed in a bespoke foot-85 
pod
iv
 (Fig. 1. e.). The foot sensor and remote control device detects foot orientation, 86 
provides voice commands during AS and acts as a handheld remote unit post AS, allowing 87 
the user to pause, and change intensity as required.  88 
Word count: 209 89 
Donning the system 90 
To don ShefStim the following steps are required: 91 
1. The footswitch (Fig. 1. f.) is placed under the heel, with the connecting cable 92 
extending from the shoe. 93 
2. The knee sleeve is donned aligning the stimulator pocket with the long axis of the 94 
tibia  95 
3. The stiŵulator is placed iŶ the kŶee sleeǀe’s stiŵulator pocket  96 
4. The foot-pod, containing the foot sensor and remote control device is positioned 97 
over the shoe locating it approximately centrally over the dorsum of the foot and 98 
attached with Velcro®  99 
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5. Electrode array placement: the centre of the third row of electrodes down from the 100 
top of the array is aligned with the head of the fibula and the inner edge parallel to 101 
the tibia.  102 
6. The electrical connector for the array (Fig. 1. g.) is inserted into the array socket on 103 
the side of the stimulator and the array is secured with a Velcro® strap. 104 
7. The self-adhesive anode is positioned over the tibialis anterior. 105 
8. The footswitch connector (Fig. 1. h.) is inserted in the stimulator. 106 
AS is then started.  107 
Word count: 177 108 
AS 109 
For a more detailed description of the AS algorithm refer to Heller’s study (1). The only 110 
difference between the algorithm used in Heller’s study (1) and the ShefStim algorithm, 111 
relates to the cost function used in stage 3 of the setup process. The cost function enables 112 
many factors that are not directly comparable (e.g. the angle of dorsiflexion (DF) and the 113 
stimulation current) to be combined into one optimisation routine. In this case, for example, 114 
the angle of DF and the stimulation current are related and the benefits of increasing DF 115 
have to be balanced against the potential disadvantages of increasing current excessively. 116 
The cost function attributes each a cost score, the lower the cost the better, and the 117 
optimisation routine is used to find a minimum cost solution. Compared with the cost 118 
fuŶctioŶ descriďed iŶ Heller’s study, the one used in ShefStim reduced the degree of 119 
eversion associated with zero cost from 10 to 5 degrees. This change was implemented 120 
following observation of excessive (>10 degrees) eversion in 19% of Heller’s participants. 121
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Word Count: 171 122 
Participants 123 
Ethical Approval was granted from the University of Salford (REP10/113) and the integrated 124 
research application system (10/H1003/107) for ten participants. Existing foot-drop FES 125 
users within the North-West region were given information by clinicians. Interested 126 
participants contacted the chief investigator. Inclusion/exclusion criteria are shown in Table 127 
1. 128 
Table 1:  129 
Word count: 46 130 
Protocol 131 
At visit 1 participants attended the University of Salford gait laboratory and were provided 132 
with standard shoes
v
  for all conditions to avoid the potential impact of different footwear  133 
on foot clearance  (13). Participants walked approximately five metres along the gait 134 
laboratory up to five times at a self-selected speed initially with no stimulation and then 135 
with participaŶt’s own FES system (self-setup). Following visit 1 the knee sleeve, stimulator 136 
and electrode arrays were prepared for that individual. Participants returned for visit 2 137 
where fitting was completed, rising/falling ramps and extension configured, adjustments 138 
made to AS settings if required (to ensure appropriate virtual electrode selection) and 139 
ShefStim use taught. Following two weeks of unsupervised use of ShefStim at home (with a 140 
home-visit after approximately one week to replenish arrays and answer any queries) 141 
participants returned to the gait laboratory (visit 3) which duplicated visit 1 but using 142 
ShefStim rather than their own FES system. 143 
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Word count: 151 144 
Measures 145 
Estimate of usage (between visits 2 and 3) 146 
Usage data has been collected in previous foot-drop FES studies (14-18). ShefStim logs the 147 
number of heel lifts per day which can be used as an estimate of usage.   148 
Word count: 29 149 
TS (visits 1 and 3) and AS time (between visits 2 and 3). 150 
With one notable exception (1), setup time has been largely neglected in previous foot-drop 151 
FES research . TS times, defined as time from first starting to don equipment to being 152 
satisfied with the outcome and walking away (including AS time for ShefStim), were 153 
recorded for participaŶts’ oǁŶ FES ;ǀisit ϭͿ aŶd ShefStiŵ ;ǀisit ϯͿ. Aǀerage AS tiŵe ;tiŵe for 154 
AS to complete) was logged by ShefStim.  155 
Word count: 65 156 
Diary recording problems during community use (between visits 2 and 3). 157 
Problems encountered were recorded in a paper diary by each participant. User-reported 158 
problems have been collected previously (15) but never during the period of use. Recorded 159 
problems were collated and grouped into two categories (19): External and Setup. External 160 
were classed as being independent of the stimulator design and so referred to the housing 161 
of ShefStim (knee sleeve), issues with the standard wired footswitch or issues with charging. 162 
Setup was defined as any problem related to setup or satisfaction with the foot response. 163 
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Word count: 81 164 
User-satisfaction (visits 1 and 3) 165 
User-satisfaction has previously been captured using purposive questionnaires (4, 15, 18). 166 
Given the risk of bias and lack of validation we sought an alternative. The Quebec User 167 
Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) device scale (20) is a 168 
validated user-satisfaction measure . Participants rated their satisfaction against eight single 169 
item criteria (dimensions, weight, ease of adjustment, safety and security, durability, ease of 170 
use, comfort, effectiveness) using a five-point Likert scale (1=not satisfied at all to 5= very 171 
satisfied: maximum score=40) for their own FES system and ShefStim.  In addition, 172 
participants ranked their top three priorities from the eight criteria. 173 
Word count: 97 174 
Speed and ankle angles at initial contact (visits 1 and 3) 175 
Increased walking speed indicates an improvement in overall walking performance (21) and 176 
is frequently used in FES research (22, 23). Measuring walking speed over five metres from a 177 
static starting position is a validated measure with neurological populations (24) and was 178 
calculated by averaging the velocity of a recorded waist marker (L3 vertebra) over the 179 
measurement space (13).  180 
Foot-drop leads to abnormal joint alignment during stance (25) with a tendency for 181 
plantarflexion (PF) and inversion (21) which can reduce ankle stability. Sagittal and frontal 182 
plane ankle angles were captured at initial contact to measure this. The calibrated 183 
anatomical system technique (CAST)(26, 27) was used for shank marker placement. Foot 184 
marker placement was based on the shod-foot model by Pratt et al. (28). 185 
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Data for both speed and ankle angles was captured at 100Hz using a 16-camera 3D motion 186 
analysis system
vi
; a fourth-order low-pass Butterworth filter was used with a 6Hz cut-off 187 
frequency. Ankle angles at initial contact were analysed using Visual 3D
vii
 188 
Word count: 152 189 
Foot clearance during swing (visits 1 and 3) 190 
Foot-drop is associated with an increased risk of tripping and falling due to a lack of foot 191 
clearance during swing phase (29). Foot clearance was obtained for seven different points 192 
on the shoe sole as described in Thies et al (13). Only three of the seven markers from Thies’ 193 
study (13) (distal toe, medial and lateral forefoot) were investigated since these were 194 
deemed most relevant. Healthy gait consistently has a minimum clearance value during 195 
swing (13, 30). Hemiplegic gait, however, has an altered clearance trajectory and does not 196 
always produce a minimum value during swing, so an alternative and consistently definable 197 
point along the trajectory was chosen. Specifically, in this study it was calculated at the 198 
moment in time when the reference point on the shoe sole passed the contra-lateral medial 199 
malleolus.  Data was processed using Matlab®
viii
 code (13). 200 
Word count: 133  201 
Total methods word count:  1311 (not including sub-headings)   202 
Data Analysis 203 
As a feasibility study (9, 31), statistical analysis was limited to graphical representation of 204 
data and descriptive methods. Ratio data (AS log data, speed and ankle angles at initial 205 
contact) was analysed using mean and standard deviation (SD). Median was used for 206 
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skewed data (usage, TS times and toe clearance (32) , with inter-quartile range(IQR)) and 207 
ordinal data (QUEST (33)).  208 
Word count: 56 209 
RESULTS 210 
Table 2:  211 
Table 2 provides participant characteristics. Prior to data collection three participants were 212 
withdrawn (1, 6, 10). The withdrawal of participants 1 and 10 was due to unrelated medical 213 
issues. Subject 6 was withdrawn as it became clear, post recruitment, that he was not a 214 
regular user of FES for foot-drop. He had discontinued use following ankle instability 215 
problems and a number of falls. The average age of the remaining  participants was 58 yrs. 216 
(SD 12.9) which is comparable to other foot-drop FES studies (1, 21, 34). Of the five men and 217 
two women, four had non-progressive and three had progressive neurological disorders, 218 
which is representative of the FES user population (16, 35). The FES systems used by 219 
participants varied but all use a single cathode and single anode, and so were classed as 220 
͚coŶǀeŶtioŶal’. 221 
Word count: 126 222 
Estimate of usage 223 
All participants used ShefStim (Fig. 2) with an average of 1314 heel lifts (steps) per day. 224 
There was variability in the number of heel lifts from day-to-day for each participant (for 225 
example participant 8) and between participants (participants 5 and 7 versus participant 3). 226 
The number of days participants used ShefStim within the two week period also varied, with 227 
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participants 7 (6/15) and 9 (4/15) using it far less than participants 5 (14/15) or 2 (13/15) 228 
(Fig. 2) 229 
Word count: 78 230 
 231 
Figure 2:  232 
 233 
TS and AS time 234 
TS time for ShefStim took an average of exactly 14 min [range: 12 min 24 s -37 min 30 s] 235 
compared to 3 min 20 s [range: 40 s -8 min] for their own FES. The average AS time was 9 236 
min [range: 7 min 34 s – 10 min 20 s]. 237 
Word count: 51 238 
 239 
Diary recording problems during community use 240 
Of the recorded problems 64% [48 problems] were related to setup with poor voice 241 
command clarity from the foot sensor and remote control device (e.g. participant 2, day 3 242 
͞reŵote ǀoice garďled͟Ϳ, frequent pausing during and/or unacceptable AS specifically cited 243 
(e.g. participant 5, day 9 ͞pausiŶg, ǁhy?͟ aŶd participaŶt Ϯ, day 2 ͞2x setups as chaplin 244 
ǁalk͟Ϳ. 36% [27 problems] were related to external issues, for example participant 8, day 6 245 
͞despite chargiŶg oǀerŶight coŶtroller ďattery ǁas flat͟. The overall number of reported 246 
problems diminished towards the end of the testing period (Fig. 3). 247 
Word count: 94 248 
 249 
Figure 3:  250 
 251 
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User-satisfaction 252 
Overall, on average, participants were as satisfied with ShefStim as with their own FES 253 
system (Fig. 4). They ǁere ŵore satisfied ǁith their oǁŶ FES iŶ terŵs of: ͚Ease of use’, ǁhich 254 
ǁas the criteria ŵost freƋueŶtly prioritised oŶ QUEST, aŶd ͚safety aŶd security’. ShefStiŵ 255 
outscored participaŶts’ own FES with regards to ͚effectiǀeŶess’, the secoŶd ŵost freƋueŶtly 256 
cited priority, aŶd ͚ease of adjustŵeŶt’. OŶ the reŵaiŶiŶg four criteria the systeŵs scored 257 
equally. 258 
Word count: 72 259 
Figure 4:  260 
 261 
Speed 262 
Both FES systems produced the same increase in walking speed [0.06 m/s] compared to no 263 
stimulation (Table 3).  264 
Word count: 18 265 
 266 
Table 3:  267 
 268 
Ankle angles at initial contact 269 
With no stimulation PF with inversion was seen (Table 3). Both ShefStim and conventional 270 
systems corrected this; however, ShefStim achieved this to a greater extent (Table 3). 271 
Word count: 27 272 
 273 
Foot clearance during swing 274 
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This outcome could not be determined for participants 5 and 7 who both exhibited short 275 
step lengths and a significant degree of external rotation of the leg during swing, therefore 276 
none of the reference points passed the contra-lateral malleolus during swing as was 277 
required by the algorithm. The distal toe marker showed the smallest overall clearance 278 
values and with ShefStim the clearance was greatest (Table 3). Table 3 shows that without 279 
FES, the median value of the medial marker was higher than the lateral; with participant’s 280 
own FES they were approximately equal and with ShefStim the lateral was higher than the 281 
medial. This foot pose at mid-swing was consistent with the ankle angles at initial contact 282 
(see above). 283 
Word count: 118 284 
Total results word count: 584 (excluding sub-headings) 285 
 286 
 287 
DISCUSSION 288 
This study sought to investigate the feasibility of unsupervised use of ShefStim by FES users 289 
within the community environment. Usage results show ShefStim is a usable device because 290 
without exception, albeit with variation, all participants used ShefStim. 291 
Previous studies have reported a number of different measures of usage (6, 14, 15, 17, 18). 292 
Only our results for steps (heel lifts) per day could be compared to previous, larger, studies 293 
(6, 15, 18), with our participants generally walking less. For example Stein et al’s (6) 294 
participants took 1842 (+/- 198) steps per day when first starting to use the Walkaide 295 
system and van Swigchem et al’s (18) took 5733 (SD 2516).  Worthy of note was that van 296 
Swigchem et al’s (18) participants were encouraged to wear the NESS L300 for the entire 297 
  
14 
 
day whereas participants in ours and Stein et al’s were not guided in this way. Further, our 298 
participants reported a number of problems associated with the pre-commercial nature of 299 
the ShefStim system, which may have impacted on use on certain days (see Fig. 3). Further 300 
studies should continue to report detailed FES usage to allow further exploration of the 301 
population and allow comparison between systems and/or baseline.  302 
Results did not fully meet the prediction made by Heller et al (1) that ShefStim would result 303 
in shorter TS times. There are a number of possible reasons for this. Firstly, Heller used self-304 
report to assess setup tiŵe ǁith participaŶts’ oǁŶ FES systeŵs, fiŶdiŶg aŶ aǀerage of ϭϭ 305 
minutes. In our study participants were timed during setup in the lab and took an average of 306 
3 minutes to setup their own FES systems. In the Heller study participants placed their 307 
affected leg in a rigid brace, thereby removing the possibility of significant leg movement. In 308 
our study, the participaŶt’s leg ǁas not constrained during setup and leg movement 309 
detected during the AS process led to pauses which lengthened the process, a problem 310 
recorded by participants.  Further, our ShefStim users relied on audio feedback from the 311 
foot sensor and remote control device, which participants reported was sometimes difficult 312 
to hear. Participants also sometimes reached the end of setup and decided that the 313 
autoŵatically choseŶ site ǁas Ŷot acceptaďle, theŶ raŶ the eŶtire AS agaiŶ. Although a ͚skip-314 
site’ fuŶctioŶ ǁas aǀailable (1) to address this issue (alternative sites identified as suitable to 315 
be selected manually) participants did not use it, hence further refinement of user training 316 
material and/or the user interface is warranted.  317 
The finding that, overall, participants were as satisfied with ShefStim as with their own FES 318 
systems, is encouraging because unlike conventional foot-drop FES systems ShefStim has 319 
not been subject to significant product design. The fact that problems diminished and ͚ease 320 
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of use’ was rated lower than participants own FES systems, however, suggests that two 321 
weeks was insufficient for participants to fully familiarise themselves with ShefStim. 322 
Alternatively it might be due to the cited problems with ShefStim itself. Our results cannot 323 
be compared to other studies as QUEST has not been used before in this field of research. 324 
Future studies should allow longer unsupervised periods of use and should use a validated 325 
measure such as QUEST.  326 
Speed increase, for both ShefStim and conventional FES systems, compared to no FES was in 327 
keeping with previous studies (21) and classed as clinically meaningful (36). IŶ Heller’s study, 328 
in which subjects did not have time to accommodate to the automated setup,  speed 329 
increase (relative to no FES) when using the automated setup system was smaller than with 330 
their own system (0.04 m/s vs 0.11m/s). In both studies foot response with AS was 331 
iŵproǀed coŵpared ǁith participaŶts’ setup of their oǁŶ stiŵulators. Although there is a 332 
risk of over-interpretation of the results, our findings may suggest that once users become 333 
accustomed to a new FES system, their walking speed is relatively insensitive to small 334 
differences in foot response. These findings are supported by the foot clearance results and 335 
indicate that the underlying operating principle of an array-based FES system with AS may 336 
be more effective at addressing foot-drop than conventional FES systems by reducing 337 
human error/influence over electrode placement. However, larger scale study is required to 338 
fully substantiate these initial findings.  339 
Word count: 676 340 
Study limitations  341 
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This was a feasibility study with a small sample size, self-referred participants and was not 342 
randomised (9, 31). As such, whilst encouraging, results should be viewed with caution. The 343 
outcome measures selected would appear appropriate but many have been largely unused 344 
in previous research in this field making comparison to previous studies challenging. 345 
Further development of the electrode-skin interface is required (12) to negate the need for 346 
daily array replacement and improve future commercial viability. Further iterations of 347 
ShefStim need to also consider addressing the cited setup and external problems, such as 348 
voice command clarity, the impact of pausing on AS time, user training and charging, to 349 
facilitate further study and widespread implementation.  350 
Word count: 110 351 
 352 
CONCLUSION 353 
This is the first study of ShefStim and one of very few investigating foot-drop FES both 354 
within the lab and during unsupervised use (37, 38). Ultimately this study demonstrates, for 355 
the first time, an array-based AS FES system (ShefStim) for foot-drop can be successfully 356 
used unsupervised. Despite longer and more problematic setup in the population studied, 357 
users were satisfied with it and it would appear to have comparable, if not better, effects on 358 
gait than conventional foot-drop FES systems. 359 
Further product development and a larger-scale, longer-term study is required before firm 360 
conclusions about the efficacy and effectiveness of ShefStim, compared to conventional FES, 361 
can be reached. 362 
Word count: 104 363 
Total word count: 3245 364 
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Suppliers 
                                                          
i
 Adidas knee support, Adidas, Herzogenaurach, Germany. 
 
ii
 Odstock Medical Ltd, Salisbury, UK 
 
iii
 5x5 PALS ®Platinum Neurostimulation electrode, Axelgaard Manufacturing co.Ltd, San 
Diego, USA. 
 
iv
 Adapted from an I-pod holder, Signalex, Birmingham, UK. 
 
v
 Hotter Comfort Concept shoes, Skelmersdale, UK. (for men) and Clarks Un Betty from 
Unstructured Autumn /Winter 2011 range, Street, UK. (for women) 
 
vi
 Qualisys, Stockholm, Sweden. 
vii
 C-Motion, Maryland, USA. 
viii
 Matlab®, Mathworks, Cambridge, UK. 
 
 
Figure legends 
 
 
Figure 1: ShefStim system (medial view of leg during AS) 
Figure 2: Logged heel lifts (N=7): Blank cells=0 heel lifts; the length of bar represents the number of 
heel lifts. The median number overall of steps per day was 1314. 
 
Figure 3: Recorded problems over two week unsupervised community use (N=7). 
 
Figure 4: Median QUEST results. Black= own FES system; Grey= ShefStim (n=7). Both systems 
scored a total of 32 out of 40. 
 
 
  
 
 
Figure 1: ShefStim (medial view of leg during AS) 
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Figure 2: Logged heel lifts (N=7): Blank cells=0 heel lifts; the length of bar represents the number of 
heel lifts. The median number overall of steps per day was 1314. 
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 Figure 3: Recorded problems over two week unsupervised community use (N=7). 
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 Figure 4: Median QUEST results. Black= own FES system; Grey= ShefStim (n=7). Both systems 
scored a total of 32 out of 40 
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Table 1: Inclusion/Exclusion criteria 
Inclusion Exclusion   Unilateral foot-drop caused by 
disorder of central neurological origin 
diagnosed at least 6 months prior to 
the study 
 Using alternative method to treat 
foot-drop (orthosis, physiotherapy, 
botulinum toxin) 
 Regular user of a foot-drop FES 
system, for at least 3 months  
 Unable to setup ShefStim, even with 
assistance  18 years of age or over   Contraindications to FES use 
  Unable to consent (<25 mini mental 
state examination)  Unable to meet protocol/ timetable 
of study  Unable to walk 5m without physical 
assistance 
Table 1
Table 2: Participant demographics. CVA= Cerebro-Vascular Accident/ Stroke; TBI=Traumatic Brain Injury; MS= Multiple Sclerosis; SPWS=Single Point Walking 
Stick; QBWS= Quad Base Walking Stick 
 Participant Age at time of 
recruitment 
Gender Diagnosis Side Affected Assistive 
device 
used 
Own FES system details 
1 58 M CVA Right SPWS  ODFS III® (Odstock Medical Ltd, Salisbury, UK) 
2 69 M CVA Left SPWS ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
3 58 F MS Right SPWS WalkAide® (Innovative Neurotronics, Austin, USA) 
4 41 M TBI Left None  ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
5 79 M CVA Right QBWS ODFS III® (Odstock Medical Ltd, Salisbury, UK) 
6 63 M CVA Right SPWS ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
7 49 F MS Right SPWS ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
8 62 M CVA Left None  ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
9 51 M MS Right None  ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
10 26 M CVA Left None  ODFS Pace® (Odstock Medical Ltd, Salisbury, UK) 
Table 2
Table 3: Average speed, ankle angles at initial contact (with SD) and foot clearance during swing 
(with IQR). =,<,> show the coŵparisoŶ relatiǀe to the participaŶt’s oǁŶ FES systeŵ. 
 
 
 
 No FES Own FES system ShefStim 
Speed (m/s) 0.72 (0.52) 0.78 (0.51) 0.78 (0.53)= 
DF (°)  -3.95 (5.89) 1.96 (5.73) 4.22 (4.64)> 
Inv (°)  9.24 (6.12) 1.65 (10.21) -1.56 (7.73)< 
Foot clearance: Distal toe (cm) 1.08 (0.62) 1.58 (0.47) 1.82 (0.89)> 
Foot clearance: Medial (cm) 2.71 (1.06) 2.50 (1.12) 2.32 (0.83)< 
Foot clearance: Lateral (cm) 1.19 (0.99) 2.38 (0.88) 2.97 (1.82)> 
Table 3
